FdaApplication
BLA 761328
Identifiers
- fda_app_no: BLA761328
Properties
| Property | Value |
|---|---|
| applicant_name | Sanofi Vaccines US Inc. |
| application_type | BLA |
| approval_date | 2023-07-17 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BEYFORTUS | NIRSEVIMAB-ALIP | 100MG/ML | Injection |
| BEYFORTUS | NIRSEVIMAB-ALIP | 50MG/0.5ML | Injection |
2 products